The country of origin is (b)(6).The customer¿s strips were requested for return.There are no more strips available for return.Product labeling states: "the coaguchek system uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas deviations can occur when compared to methods using other thromboplastins.However, those deviations between thromboplastins of different origin (e.G., rabbit based) are not specific to coaguchek products.Similar differences can be observed when a human recombinant thromboplastin based laboratory method is compared to other laboratory methods." relevant retention test strips (lot 424008) were tested in comparison with the master lot coaguchek xs pt.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.Retention samples were acceptable.No error messages occurred.The corresponding retention material complies with the specification, based on the requirements of the regular retention testing process of the qc department.No error messages occurred.The investigation did not identify a product problem.The cause of the event could not be determined.
|
The initial reporter complained of a discrepant inr result with coaguchek pro ii meter serial number (b)(4) when compared to a laboratory result using an unknown method.The meter result was 7.7 inr and within 20 minutes the laboratory result was 4.5 inr.The meter result about 5 minutes later, using a different finger, was 7.5 inr.The clinic stopped the patient's warfarin dose for 1 day and retested him the next day on (b)(6) 2020 and received a result of 4.6 inr.The patient's therapeutic range is 2.0-3.0 inr.
|